LEP and obesity disorder: On the other hand, sodium valproate might directly affect adipose tissues’ adipokines, such as adiponectin, leptin, and ghrelin, contributing to changes in fatty acid oxidation, weight gain, enhancing patient’s appetite, influencing glucose and insulin metabolism that leads to obesity, and higher body fat proportion (27-30).